×

Clinical Development Platform

Complete Package for Clinical Trials

Whether your drug development journey with WuXi started in early discovery or post-IND, the Laboratory Testing Division offers sample analysis to support your clinical trials across all phases, ensuring a seamless progression from preclinical to clinical development.

Single Solution from Early to Late-Stage

When you engage WuXi as your drug development partner, you not only benefit from the multidisciplinary experience of our scientific teams, but also the continuous knowledge gained from working with your compound from start to finish. Our integrated approach enables us to become deeply familiar with the intricacies of your project and make informed, strategic decisions moving from preclinical through clinical trials.

Bioanalytical
+ Small molecule and biologics quantitation
+ Generic/biosimilar and innovator study support
+ Biomarker testing

DMPK
+ PK Met ID
+ Mass Balance (hot & cold)
+ CYP, Phase II enzyme and transporter substrate phenotyping

Toxicology
+ Chronic and subchronic toxicology
+ Seg I-III DART studies
+ Carcinogenicity studies
+ Juvenile toxicology
+ 4-week batch impurity testing

Analytical Testing
+ Late-phase commercial analytical development
+ Stability studies
+ Regulatory CMC
+ Project management